Darius Rares Rad

Dr. Darius Rares Rad

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2025 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
TVThemistoklis Vampertzis
Themistoklis Vampertzis
SKSuraj Kohli
Suraj Kohli
ESEmmanuel Spanoudakis
Emmanuel Spanoudakis
PSPanagiotis Sgardelis
Panagiotis Sgardelis
ASAthanasios Serlis
Athanasios Serlis
FWFarokh Wadia
Farokh Wadia

27 November 2025 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
GMGeorge Matheron
George Matheron
FWFarokh Wadia
Farokh Wadia
DEDeborah Eastwood
Deborah Eastwood
ESEmmanuel Spanoudakis
Emmanuel Spanoudakis
KCKaren Chui
Karen Chui
TVThemistoklis Vampertzis
Themistoklis Vampertzis

23 February 2026 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
ESEmmanuel Spanoudakis
Emmanuel Spanoudakis
AAAlexander Aarvold
Alexander Aarvold
FWFarokh Wadia
Farokh Wadia
DRDarius Rares Rad
Darius Rares Rad
NSNeil Segaren
Neil Segaren
TVThemistoklis Vampertzis
Themistoklis Vampertzis

4 June 2025 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Open access
PDF file
ESEmmanuel Spanoudakis
Emmanuel Spanoudakis
TVThemistoklis Vampertzis
Themistoklis Vampertzis
FWFarokh Wadia
Farokh Wadia
DRDarius Rares Rad
Darius Rares Rad
CBChristina Barmpagianni
Christina Barmpagianni
NGNikiforos Galanis
Nikiforos Galanis
Purpose: Using botulinum toxin (BoNT) as an adjunct in fracture management is a novel approach with the potential to improve clinical outcomes, particularly in atypical fractures and patients with concurrent neuromuscular disorders. This scoping review explores the literature on BoNT’s effectiveness in facilitating fracture healing and immobilisation across various fracture types. Methods: The PubMed, Embase, and Cochrane databases were searched with defined operators. Two investigators conducted independent searches, which were combined. Animal studies, case reports, case series, cohort reviews and randomised control trials were included. Results: Fifty studies were identified for screening, from which 15 studies were included in the review. The findings highlight mixed outcomes in BoNT’s role in enhancing bone healing and reducing muscle-induced displacement. While BoNT injections demonstrated potential benefits in specific cases, such as atypical fractures, periprosthetic fractures and fractures in patients with motor dysfunctions, results from animal studies were inconsistent, showing varied effects on callous formation and bone mineral density. Conclusion: Clinical applications of BoNT in fracture management indicate its utility as an immobilisation agent to promote fracture healing and reduce complications. However, this review highlights that further research is necessary to bridge the gap between experimental and clinical studies and to clarify BoNT’s effectiveness in different use cases.